The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

Oramed (ORMP) targets a new patient subset after FDA setback. Learn how promising trials may revive its protein oral delivery ...

The Mutual Fund Assets Market was valued at 568.3 Billion in 2023 and is expected to reach 1,171.3 Billion by 2033, with a ...

Standard treatments can significantly lower the risk of stroke in children with sickle cell anemia, according to a review of ...

In Chicago’s working-class Pilsen neighborhood, a 60s-era oil-fired power plant rises up from an industrial lot behind Dvorak ...

Review of 1 million women finds no clear link between hormone therapy and dementia risk. Evidence certainty is low with ...

The data center boom continues in Wisconsin. But what are data centers, and why are people upset about them coming to our ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Have you ever wondered how your personality is related to how you do in life? Estonian researchers have put together a large overview of personality profiles – a so-called “personality atlas” that ...

Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

A new pooled analysis of the FIBRONEER™-IPF and FIBRONEER™-ILD trials resulted in a nominally significant reduction in the risk of death by 59% in patients who received 18mg nerandomilast without ...